Movement Disorders (revue) - Analysis (USA)

Index « Auteurs » - entrée « Joseph Friedman »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Joseph Ferrara < Joseph Friedman < Joseph G. Hentz  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 4.
Ident.Authors (with country if any)Title
000596 (2011) Joseph Friedman [États-Unis]Neuropsychiatric symptoms in Parkinson's disease
000C96 (2007) Joseph Friedman [États-Unis]Re: Clinical feature profile of spinocerebellar ataxia type 1–8 predicts genetically defined subtypes
001094 (2005) Anelyssa D'Abreu [États-Unis] ; Joseph Friedman [États-Unis] ; Jim Coskun [États-Unis]Non‐movement disorder heralds symptoms of Machado‐Joseph disease years before ataxia
001258 (2004) Matthew B. Stern [États-Unis] ; Kenneth L. Marek [États-Unis] ; Joseph Friedman [États-Unis] ; Robert A. Hauser [États-Unis] ; Peter A. Lewitt [États-Unis] ; Daniel Tarsy [États-Unis] ; C. Warren Olanow [États-Unis]Double‐blind, randomized, controlled trial of rasagiline as monotherapy in early Parkinson's disease patients

List of associated KwdEn.i

Nombre de
documents
Descripteur
4Humans
2Adult
2Female
2Male
2Middle Aged
2Nervous system diseases
2Parkinson Disease (complications)
1Aged
1Ataxia
1Ataxia (etiology)
1Ataxia (genetics)
1Autonomic Nervous System Diseases (diagnosis)
1Autonomic Nervous System Diseases (genetics)
1Behavioral disorder
1Cramp
1Diagnosis, Differential
1Disease Progression
1Dose-Response Relationship, Drug
1Double-Blind Method
1Follow-Up Studies
1Human
1Incidence
1Indans (pharmacokinetics)
1Indans (therapeutic use)
1Joseph disease
1Lewy Body Disease (diagnosis)
1Lewy Body Disease (genetics)
1Machado-Joseph Disease (complications)
1Machado-Joseph Disease (genetics)
1Machado‐Joseph disease
1Mental Disorders
1Mental Disorders (epidemiology)
1Mental Disorders (etiology)
1Monoamine Oxidase Inhibitors (pharmacokinetics)
1Monoamine Oxidase Inhibitors (therapeutic use)
1Movement Disorders (etiology)
1Movement Disorders (genetics)
1Multicenter Studies as Topic
1Neurologic Examination
1Parkinson Disease (drug therapy)
1Parkinson Disease (epidemiology)
1Parkinson disease
1Parkinson's disease
1Peripheral neuropathy
1REM Sleep Behavior Disorder (etiology)
1REM Sleep Behavior Disorder (genetics)
1REM sleep behavior disorder
1Rapid eye movement sleep
1Rasagiline
1Severity of Illness Index
1Sleep Disorders (diagnosis)
1Sleep Disorders (genetics)
1Sleep disorder
1Spinocerebellar Ataxias (classification)
1Spinocerebellar Ataxias (diagnosis)
1Spinocerebellar Ataxias (genetics)
1Time Factors
1Treatment Outcome
1cramps
1monoamine oxidase inhibitors
1monotherapy
1non‐motor manifestations
1peripheral neuropathy
1rasagiline
1safety
1tolerability

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/USA/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/USA/Analysis/Author.i -k "Joseph Friedman" 
HfdIndexSelect -h $EXPLOR_AREA/Data/USA/Analysis/Author.i  \
                -Sk "Joseph Friedman" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/USA/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    USA
   |étape=   Analysis
   |type=    indexItem
   |index=    Author.i
   |clé=    Joseph Friedman
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024